AI assistant
Sending…
Ascelia Pharma — Major Shareholding Notification 2021
Jan 15, 2021
3132_iss_2021-01-15_0721ab25-4cc8-477f-b544-bfa79ee2f249.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Ascelia Pharma AB
Holder
CMC SPV of 3 April 2017 AB
Instrument
Instrument Common shares SE0010573113
| Before the transaction | ||
|---|---|---|
| Shares | Data not given* | |
| Voting rights | 0 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 14/01/2021 | |
| Limit for number of shares | 10 % | |
| Limit for number of votes | 10 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 0 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 0 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 0 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total
Group total holdings
Voting rights 0 Percentage of voting rights 0
Published
15/01/2021 10:08
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Ascelia Pharma
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 23
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Mar 30